Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (471-480 of 683) with videos related to

Pageof 69
Sort By:
Plos One|December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancerMihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Cancers|December 23, 2022
Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian CancerTomi Akinyemiju, Ashwini Joshi, April Deveaux, et al.
Molecular Carcinogenesis|December 30, 1998
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7qO van der Heijden, H C Chiu, T C Park, et al.
Nature Genetics|June 1, 1996
BRCA2 mutations in primary breast and ovarian cancersJ M Lancaster, R Wooster, J Mangion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu, Andrea P Patterson, Lin Wang, et al.
BMC Pediatrics|June 28, 2020
Rationale and design of "Hearts & Parks": study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesitySarah C Armstrong, McAllister Windom, Nathan A Bihlmeyer, et al.
Gynecologic Oncology|June 12, 2026
Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly diagnosed advanced-stage epithelial ovarian cancer: the AdORN studyStéphanie Gaillard, Jack Parker, Gloria Broadwater, et al.
Oncotarget|October 3, 2015
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancerEdward J Richards, Jennifer Permuth-Wey, Yajuan Li, et al.
The Oncologist|July 11, 2026
Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Michelle Jayaraj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Pageof 69

Showing results (471-480 of 683) with videos related to

Sort By:
Pageof 69
Plos One|December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancerMihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Cancers|December 23, 2022
Development and Psychometric Evaluation of Healthcare Access Measures among Women with Ovarian CancerTomi Akinyemiju, Ashwini Joshi, April Deveaux, et al.
Molecular Carcinogenesis|December 30, 1998
Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7qO van der Heijden, H C Chiu, T C Park, et al.
Nature Genetics|June 1, 1996
BRCA2 mutations in primary breast and ovarian cancersJ M Lancaster, R Wooster, J Mangion, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu, Andrea P Patterson, Lin Wang, et al.
BMC Pediatrics|June 28, 2020
Rationale and design of "Hearts & Parks": study protocol for a pragmatic randomized clinical trial of an integrated clinic-community intervention to treat pediatric obesitySarah C Armstrong, McAllister Windom, Nathan A Bihlmeyer, et al.
Gynecologic Oncology|June 12, 2026
Atezolizumab in combination with neoadjuvant chemotherapy and interval cytoreductive surgery for patients with newly diagnosed advanced-stage epithelial ovarian cancer: the AdORN studyStéphanie Gaillard, Jack Parker, Gloria Broadwater, et al.
Oncotarget|October 3, 2015
A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancerEdward J Richards, Jennifer Permuth-Wey, Yajuan Li, et al.
The Oncologist|July 11, 2026
Novel Risk Scoring System for Patients with Metastatic Castration Resistant Prostate Cancer Treated with Lutetium-177-PSMA-617Margo B Gerke, Angelo Marra, Michelle Jayaraj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancerJanos L Tanyi, Yutaka Hasegawa, Ruth Lapushin, et al.
Pageof 69